Company Profile
Jilin Haotai Health Industry Development Co., Ltd. was established in 2018 with a registered capital of 50 million yuan. The company's address is Changchun Xinglong Comprehensive Bonded Zone. The company is engaged in the biomedical health industry, is a research and development, production, sales as one of the diversified technology companies. The company is a national science and technology small and medium-sized enterprise, a national high-tech enterprise, and an enterprise listed on the Jilin Provincial Stock Exchange (stock code: 520023). The company has achieved 15 scientific and technological achievements transformation, the average annual transformation of 5. It has 12 intellectual property rights within the validity period, including 9 invention patents, 3 utility model patents and 7 novelty search reports. 5 registered trademarks and 1 copyright.
The company has a strong scientific research team and rich resources. The advisory group composed of domestic experts and scholars has established a strong technical support for the research and development of Haotai Health's professional products; by Jilin Business College, Changchun University of Traditional Chinese Medicine, Jilin University, Ocean University of China, Jiangsu Ocean University, Yantai University, Beijing Institute of Genomics, Chinese Academy of Sciences, Institute of Semiconductors, Chinese Academy of Sciences, etc. Experts and professors in the fields of science, as well as elites with strong scientific research teams with rich experience from all over the world, it has laid a solid foundation for providing high-quality health products and health management services to customers.
On October 21, 2022, Jilin Haotai Health Industry Development Co., Ltd. established Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd., a wholly-owned subsidiary of Haotai Health, with 50 million registered capital and registered address: Jilin Huinan Economic Development Zone. Mainly engaged in pharmaceutical intermediates and API projects.
In April 2024, a wholly-owned subsidiary, Haotai Juyuan (Jilin) Pharmaceutical Co., Ltd. was established. Registered address: Helong City, Yanbian Prefecture, with a registered capital of 50 million yuan. Haotai Juyuan (Jilin) Pharmaceutical Co., Ltd. is an important part of improving Haotai Health (head office) in the industrial layout of animal-derived pharmaceutical intermediates. Persist in uniting with universities, scientific research institutes, and institutes, continuously research and develop new varieties and new projects, and adhere to the strategic goal of sustainable development. Research and development with the characteristics of the enterprise halal series products (cattle, sheep source), traditional natural medicine products, so that the development of enterprises sustained stamina.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.